IDENTIFYING PRESUMPTIVE CELIAC DISEASE IN HIGH RISK POPULATIONS

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 中心，不一定是研究者的机构。 第一章 确定乳糜泻风险增加人群和抗体筛查受限人群中血清伊加组织转氨酶抗体阳性的患病率。 （二） 确定乳糜泻高风险人群中风险因素、症状和症状持续时间的患病率，以及基于抗体的筛查有限的人群 第三章 确定患者寻求乳糜泻抗体筛查的主要原因。 四、 确定获得乳糜泻抗体筛查的障碍。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. 1) Determine the prevalence of positive serum IgA tissue transglutaminase antibody among populations at increased risk for celiac disease and who have limited access to antibody-based screening. 2) Determine the prevalence of risk factors, symptoms, and duration of symptoms among populations at high risk for celiac disease and limited access to antibody-based screening 3) Determine the major reasons why patients seek antibody-based screening for celiac disease. 4) Determine the barriers to obtaining antibody-based screening for celiac disease.